For research use only
| Cat No. | ABC-TC0379 |
| Product Type | Mouse Liver Cancer Cell Lines |
| Species | Mouse |
| Growth Conditions | 37 ℃, 5% CO2 |
| Product Code | HEPCBR-C9, HEP CBR C9, HEP-CBRC9 |
HEP-CBR-C9 cell line offers a hepatic research model supporting drug metabolism, liver disease mechanism studies, and toxicity testing applications.
HEP-CBR-C9 cell line was derived from a primary hepatocellular carcinoma developed in C3H/He mice. The tumors were induced through a single intraperitoneal injection of N-nitrosodiethylamine (NDEA), creating a laboratory model that closely simulates the natural progression of liver cancer. No published karyotype data is currently available. Studies using HEP-CBR-C9 cells enable researchers to gain insights into how normal hepatocytes transform into malignant cells and how these cancer cells grow and metastasize. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | HEPCBR-C9, HEP CBR C9, HEP-CBRC9 |
| Species | Mouse |
| Cat.No | ABC-TC0379 |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Mouse Liver Cancer Cell Lines |
HEP-CBR-C9 cell line is suited for studies of liver-specific gene regulation, enzyme function, and cancer biology. They support mechanistic research into hepatocyte differentiation, carcinogenesis, and intracellular signaling pathways. The cell line is also applicable in screening for liver-targeted drugs and modeling liver tissue responses in vitro. These cells thus serve as a versatile tool for bridging basic research and translational studies in liver-related fields.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
